Skip to main content
Have a personal or library account? Click to login
Macromolecular prodrugs. XII. Primaquine conjugates: Synthesis and preliminary antimalarial evaluation Cover

Macromolecular prodrugs. XII. Primaquine conjugates: Synthesis and preliminary antimalarial evaluation

Open Access
|Mar 2009

References

  1. S. Vangapandu, S. Sachdeva, M. Jain, S. Singh, P. P. Singh, C. L. Kaul and R. Jain, 8-Quinolinamines and their pro prodrug conjugates as potent blood-schizontocidal antimalarial agents,(2003) 4557-4568; DOI: 10.1016/j.bmc.2003.07.003.
  2. N. Vale, R. Moreira and P. Gomes, Primaquine revisited six decades after its discovery,(2008) (in press); DOI: 10.1016/j.ejmech.2008.08.011.
  3. R. Jain, S. Jain, R. C. Gupta, N. Anand, G. P. Dutta and S. K. Puri, Synthesis of amino acid derivatives of 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-substituted/4,5-disubstituted-quinolines as potential antimalarial agents,(1994) 251-254.
  4. M. Jain, S. Vangapandu, S. Sachdeva and R. Jain, Synthesis and blood-schizontocidal antimalarial activities of 2-substituted/2,5-disubstituted-8-quinolinamines and some of their amino acid conjugates,(2004) 1003-1010; DOI 10.1016/j.bmc.2003.12.029.
  5. R. Borissova, P. Stjärnkvist, M. O. Karlsson and I. Sjöholm, Biodegradable microspheres. 17. Lysosomal degradation of primaquine-peptide spacer arms,(1995) 256-262.
  6. P. Stjärnkvist, Biodegradable microspheres: XIV. Effect of microparticle-bound primaquine onin mice,(1993) 23-32; DOI: 10.1016/0378-5173(93)90208-W.
  7. A. Trouet, P. Pirson, R. Baurain and M. Masquelier,, in, Vol., Part 2, Springer-Verlag, Berlin 1984, pp. 253-264.
  8. R. Duncan,, in(Eds. V. Muzykantov and V. Torchilin), Kluwer Academic Publishers, Norwell 2002, pp. 193-209.
  9. R. Duncan, The dawning era of polymer therapeutics,(2003) 347-360; DOI: 10.1038/nrd1088.
  10. P. Mayorga, E. Deharo, F. Puisieux and G. Couarraze, Interpretation and prediction of plasma levels of primaquine following transdermal delivery in Swiss mice,(1997) 99-107.
  11. A. A. Date, M. D. Joshi and V. B. Patravale, Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles,(2007) 505-521; DOI: 10.1016/j.addr.2007.04.009.
  12. A. M. Dierling and Z. Cui, Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy,(2005) 143-152; DOI: 10.1016/j.ijpharm.2005.07.015.
  13. G. Džimbeg, B. Zorc, M. Kralj, K. Ester, K. Pavelić, J. Balzarini, E. De Clercq and M. Mintas, The novel primaquine derivatives of-alkyl, cycloalkyl or aryl urea: synthesis, cytostatic and antiviral activity evaluations,(2008) 1180-1187; DOI: 10.1016/j.ejmech.2007.09.001.
  14. J. Vlasák, F. Rypáček, J. Drobník and V. Saudek, Properties and reactivity of polysuccinimide,(1979) 59-64.
  15. M. Lovrek, B. Zorc, B. Boneschans and I. Butula, Macromolecular prodrugs. VIII. Polymer-gemfibrozil conjugates,(2000) 59-66; DOI: 10.1016/S0378-5173(00)00340-9.
  16. G. Antoni, C. Arezzini, F. Cocola, G. Gazzei and P. Neri, Pharmacological and toxicological evaluation of polyhydroxyethylaspartamide (PHEA) as a plasma substitute,(1979) 146-156.
DOI: https://doi.org/10.2478/v10007-009-0007-x | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English, Croatian
Page range: 107 - 115
Published on: Mar 20, 2009
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2009 Zrinka Rajić, Gabrijela Kos, Branka Zorc, Prati Singh, Savita Singh, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.